These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23382798)

  • 1. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.
    Chen P; Li M; Gu X; Liu Y; Li X; Li C; Wang Y; Xie D; Wang F; Yu C; Li J; Chen X; Chu R; Zhu J; Ou Z; Wang H
    PLoS One; 2013; 8(1):e49312. PubMed ID: 23382798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan.
    Shamsi U; Khan S; Azam I; Habib Khan A; Maqbool A; Hanif M; Gill T; Iqbal R; Callen D
    PLoS One; 2020; 15(1):e0225402. PubMed ID: 31967989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    J Nutr; 2016 Mar; 146(3):576-85. PubMed ID: 26817718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
    Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
    Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
    Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
    J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
    Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
    Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
    Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
    Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
    Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
    Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
    Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
    Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
    Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
    Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
    J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
    Kim Y; Je Y
    Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
    Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
    Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
    Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum 25 hydroxyvitamin D in breast cancer: An Indian scenario.
    Patel SR; Patel KD; Patel KR; Gokani RA; Patel JB; Patel PS; Shah FD
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105726. PubMed ID: 32682059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
    Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
    Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
    Abbas S; Chang-Claude J; Linseisen J
    Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.